Wafra’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-333,234
Closed -$43.1M – 73
2023
Q1
$43.1M Sell
333,234
-107,381
-24% -$13.5M 1.53% 23
2022
Q4
$56.2M Hold
440,615
– – 2.15% 13
2022
Q3
$46.1M Buy
440,615
+4,625
+1% +$508K 1.82% 17
2022
Q2
$45.8M Buy
435,990
+2,238
+0.5% +$266K 1.74% 17
2022
Q1
$55.5M Buy
433,752
+3,381
+0.8% +$408K 1.92% 18
2021
Q4
$54.7M Buy
+430,371
New +$58M 1.73% 20

Other funds holding ZBH

Wafra's ZBH Position: Q2 2023 in Review

Wafra sold out of Zimmer Biomet (ZBH) in Q2 2023, closing a stake of 333,234 shares — an estimated $43.1M sold.

Wafra first reported a position in ZBH in Q4 2021 and held it in 6 quarters. The position peaked at $56.2M in Q4 2022. 1,027 funds tracked by Wall St. Rank hold ZBH as of Q2 2023.

  • Wafra reported no remaining Zimmer Biomet position as of Q2 2023 after selling out during the quarter.
  • Wafra sold 333,234 Zimmer Biomet shares in Q2 2023, an estimated $43.1M.
  • Wafra first reported a position in Zimmer Biomet in Q4 2021 and held it in 6 quarters.
  • Wafra's Zimmer Biomet position peaked at $56.2M in Q4 2022.
  • 1,027 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2023.

Based on Wafra's 13F filing for Q2 2023, filed 21 Jul 2023.